GovChime
Notice ID: 07cb7d5e1b5c4f1c85c21dc21bbc6d1fAward NoticeAwardedArchived

SIRTEX SIR-Spheres Y-90 Microspheres

Awarded on August 19, 2026. Full description on SAM.gov.

Awarded tounder HT941026PE151 (source: SAM.gov award notice)• $23.4K

Overview

Posted
August 19, 2026
Notice type
Award Notice
Set-aside
No Set aside used
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY HCD WEST
Place of performance
Washington, 98011
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Aug 19, 2026
Award amount (SAM.gov award notice)
$23.4K

Identifiers

Solicitation number
HT941026PE151
Notice ID
07cb7d5e1b5c4f1c85c21dc21bbc6d1f
Award number (PIID)
HT941026PE151

Description

Contract Award HT941026PE151 - SIRTEX SIR-Spheres Y-90 Microspheres

Full description on SAM.gov

Award Overview

Award Number

HT941026PE151

Award Amount (SAM.gov award notice)

$23.4K

Award Date

Aug 19, 2026

Awardee

Awardee UEI

CWH2GM13A2V6

Awardee CAGE Code

45EE6

Awardee Address

Woburn, MA 01801, UNITED STATES

Original Solicitation

Notice ID: 07cb7d5e1b5c4f1c85c21dc21bbc6d1f

Posted Date: Aug 19, 2026

Original Response Deadline: Not specified

Contract Details

Contract data not yet available

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (1)

  • Contract - HT941026PE151.pdf

    2.2 MBAdded in Award Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Award NoticeArchivedCurrent

    SIRTEX SIR-Spheres Y-90 Microspheres

    Notice 07cb7d5e1b5c4f1c85c21dc21bbc6d1f on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The VA Puget Sound Health Care System Pathology and Laboratory Medicine Service requires a histology staining workflow system which includes: Two (2) immunohistochemistry (IHC) and two (2) in-situ hybridization (ISH) immunostainers, and two (2) special stainers, and a specimen tracking system which promotes proper identification of specimens and slides and will audit workflow to identify areas that need improvement and reduce errors. The tracking system will improve patient safety, provide a chain of custody, and will monitor productivity. All the components of the workflow system must communicate with each other in order to track the workflow. The stainers attached to this system must be automated and allow the system to track and label slides for special staining and immunostaining. The workflow system must be compatible with the IT systems VISTA and/or Cerner, as well as any other new electronic health record system the VA acquires and also be compatible with Data Innovations middleware.
-Market Research11/13/2026
Procurement of rapid syndromic molecular testing reagents for the Seattle VA Medical Center. Please see Attachments for further information in regards to this acquisition.
-Market Research08/06/2027
This RFI does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. Item 0001: OXYGEN, USP, FILLED CYLINDER, SIZE D, 95GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5181 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0002: OXYGEN, USP, FILLED CYLINDER, SIZE H, 1650 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-132-5199 Shall be made in accordance with MIL-O-37997 DATED 18 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. Item 0003: NITROUS OXIDE, USP, FILLED CYLINDER, SIZE D, 250 GAL, TYPE I-DOT 3AA STEEL NSN: 6505-00-130-1920 Shall be made in accordance with MIL-N-37996 DATED 24 DECEMBER 1985 (attached) and changes listed in the attachment to this notice. ----------------------------------------------------- The Defense Logistics Agency Troop Support is seeking sources capable of providing the Medical Gas Cylinder in accordance with the Military Specifications listed above. NOTE: Only Type I-DOT 3AA STEEL Medical Gas Cylinders are acceptable. If your firm currently manufactures or distributes Type I-DOT 3AA STEEL Medical Gas Cylinders in accordance with the Military Specifications and changes attached, please provide information with respect to the following: Source and Part Number being supplied for each type of cylinder Place of manufacture for each type of cylinder Source for the Medical Gases Current unit sale price for each type of cylinder prefilled with the medical grade gas Estimated annual capacity for each type of cylinder/medical grade gas Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the ATNAA. All information submitted shall remain with the U.S. Government and will not be returned. It will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically via emailed to Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil
-Market Research11/15/2026
Please see attached for the sources sought notice/market research survey and MPID.
-Market Research11/30/2026
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following November 2026 newly approved drugs will be reviewed: a. Adquey - Atopic - Subclass: Topical Agents b. Armlupeg - White Blood Cell Stimulants - Subclass: Pegfilgrastims c. Beqalzi - Oncological Agents - Non-BTKI for Chronic Lymphocytic Leukemia-Small Lymphocytic Lymphoma d. Bixlenvo - Antiretrovirals - Subclass: Combinations e. Clotic - Antifungals - Subclass: NA f. Etcamah - Breast Cancer Agents - Estrogen Receptor Antagonist g. Langlara - Insulins - Subclass: Basal h. Lisraya - Targeted Immunomodulatory Biologics – NA i. Mimrylo - Hematological Agents – NA j. Nuzolvence - Antibiotics – NA k. Rasonque - Oncological Agents - Subclass: RAS Inhibitors l. Rezenopy - Alcohol Deterrants - Narcotic Antagonists The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9404. Pre-quotation teleconference is on October 14, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.
-Solicitation10/26/2026

Additional Details

Solicitation Number

HT941026PE151

Archive Date

Sep 3, 2026

Office Address

CAMP PENDLETON, CA, 92055